1. Home
  2. GIGM vs IRIX Comparison

GIGM vs IRIX Comparison

Compare GIGM & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GIGM

GigaMedia Limited

N/A

Current Price

$1.40

Market Cap

15.9M

Sector

Technology

ML Signal

N/A

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$1.14

Market Cap

18.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GIGM
IRIX
Founded
1998
1989
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.9M
18.2M
IPO Year
2002
1996

Fundamental Metrics

Financial Performance
Metric
GIGM
IRIX
Price
$1.40
$1.14
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.4K
63.8K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
51.85
EPS
N/A
N/A
Revenue
N/A
$41,593,000.00
Revenue This Year
N/A
$3.07
Revenue Next Year
N/A
$6.66
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.29
$0.87
52 Week High
$1.89
$1.65

Technical Indicators

Market Signals
Indicator
GIGM
IRIX
Relative Strength Index (RSI) 46.72 57.41
Support Level $1.30 $0.99
Resistance Level $1.49 $1.21
Average True Range (ATR) 0.04 0.05
MACD -0.00 0.01
Stochastic Oscillator 27.27 67.74

Price Performance

Historical Comparison
GIGM
IRIX

About GIGM GigaMedia Limited

GigaMedia Ltd is a diversified provider of digital entertainment services. The only segment and principal business of the company is digital entertainment service business, that operates a portfolio of digital entertainment products, targeting digital entertainment service users across Asia. The company operates digital entertainment business in Taiwan, Hong Kong and Macau through FunTown. The company generates majority revenue from Taiwan.

About IRIX IRIDEX Corporation

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: